Skip to content

Clinical trials

Phase 3 Intestinal Diseases trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Intestinal Diseases Phase: Phase 3 Country / region: France Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20091
20111
20141
20151
20162
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting2
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Zealand Pharma2
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)1
Hospices Civils de Lyon1
Medtronic - MITG1
Menarini Group1
Pfizer1
Shield Therapeutics1
Sumitomo Pharma America, Inc.1
University Hospital, Bordeaux1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Intestinal Diseases10
Digestive System Diseases5
Gastrointestinal Diseases5
Colonic Diseases3
Colorectal Neoplasms3
Digestive System Neoplasms3
Gastrointestinal Neoplasms3
Intestinal Neoplasms3
Neoplasms by Site3
Rectal Diseases3

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.